Abstract:Objectives To evaluate the mid-term clinical and echocardiographic:outcomes of tricuspid valve plasty(TVP), to compare the curative effect of different tricuspid annuloplasty techniques,and to identify the risk factors of postoperative residual tricuspid regurgitation(PRTR).Methods From August 2005 to February 2007,222 patients underwent tricuspid annuloplasty for functional tricuspid regurgitation(FTR) in the Department of Cardiac Surgery of Zhongshan Hospital,Fudan University. Male 89 cases(40.1%),female 133 cases(59.9%),aged(50.0±12.0) years,using 2 main techniques:non-ring procedure in 136 patients(61.3%),and ring procedure in 86 patients(38.7%).Postoperative follow-ups were performed using echocardiography and New York Heart Association(NYHA) classification.Mid-term outcomes of TVP was analyzed.The determinants of PRTR were identified,and the curative effect of different tricuspid annuloplasty techniques was compared,by means of clinical and echocardiographic follow-ups.Results There were 2 perioperative death(0.9%),with no diffrerence between two groups(P= 0.588). Mean follow-up time was(24.4±10.9) months(15 days to 42 months),and 20 cases(9.0%) lost to follow-up.Mean preoperative TR grade was(2.5±1.1) +,and mean postoperative TR grade was(0.7±0.8) +(P< 0.01).Mean preoperative NYHA was 3.1±0.5,and mean postoperative NYHA was 1.4±0.5(P< 0.01).PRTR occurred in 27 cases(13.5%).Tricuspid reoperation rate was 0%,and survival rate was 97.5%.The severity of preoperative TR was higher in ring group(P< 0.01),and the severity of postoperative TR was similar(P=0.269).In patients with preoperative TR 3+ to 4+,the severity of postoperative TR in ring group was lower than non-ring group(P=0.044). The change rate of TR was higher in ring group(P=0.021).When preoperative atrial fibrillation(P=0.001),leftatrium(LA) > 60 mm(P=0.011), systolic pulmonary artery pressure(sPAP) > 65 mmHg(P=0.036) or TR 3+ to 4+(P=0.047),ring group shared higher change rate of TR than non-ring group.In multivariate analysis,rheumatic etiology(P=0.026,OR = 9.9),postoperative right atrium size(P=0.003,OR =2.9),less postoperative left ventri cular ejection fraction(LVEF)(P=0.025,OR= 4.4),postoperative sPAP>50 mmHg(P=0.029,OR =4.2),and higher postoperative sPAP(P=0.020,OR= 4.9) were independent risk factors of PRTR.Conclusions TVP is an effective procedure treating FTR.The echocardiographic mid-term outcome in ring group is better than that in non-ring group,especially when preoperative TR 3+ to 4+,or when preoperative atrial fibrillation,huge LA or pulmonary artery hypertension.Rheumatic etiology,postoperative right atrium size,less postoperative LVEF,postoperative pulmonary artery hypertension and higher postoperative sPAP show independent association with PRTR.

Effect of electronic device implantation on tricuspid valve function

Association Between Cardiovascular Implantable Electronic Devices and Tricuspid Regurgitation: a Case-Control Study.

Assessment of the effects of cardiac rhythm device implantation on right sided heart function and tricuspid valve

Tricuspid Annulus Dilation in Patients with Combined Functional Tricuspid Regurgitation and Left-Heart Valvular Disease: Does Septal Annulus Not Dilate?

Cardiac Pacemaker and the Effect on Hemodynamics of the Tricuspid Valve

Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta‐analysis

Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design

Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy

Association of late tricuspid regurgitation progression and intracardiac lead types in patients after primary implantation of cardiac electronic devices

Tricuspid Regurgitation Following Implantation of a Pacemaker/Cardioverter-Defibrillator

Incidence and Predictors of Permanent Pacemaker Implantation in Patients Who Underwent Transcatheter Aortic Valve Replacement: Observation of a Chinese Population.

Abstract 15350: Differing Impacts of Cardiac Implantable Electronic Device Leads on Tricuspid Regurgitation

Abstract 8803: Bioprosthetic Tricuspid Valve Regurgitation Associated with Device Lead Implantation

Incidence, time course, and outcomes of worsening tricuspid regurgitation following transvenous cardiac implantable electronic device implantation

Tricuspid regurgitation burden following transcatheter aortic valve replacement requiring early pacemaker implantation

Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis

Phenotype of severe tricuspid regurgitation induced by intracardiac pacing devices

Determinants of mid-term outcomes of tricuspid annuloplasty for functional tricuspid regurgitation:an echocardiography study

Tricuspid Regurgitation Associated with Implantable Cardiac Devices: A Double-Edged Sword

Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Tricuspid Regurgitation Induced by Implantable Device Leads.

Cardiac implantable electronic device‐induced tricuspid regurgitation: Implications and management